MTD · NYQ · Healthcare
Mettler-Toledo International Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 696.04
Market price
USD 1678.19
Implied upside
-58.5%
10-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · Price 2026-11-02 · Accounts to 2025-12-31
Current EV/EBITDA of 28.7x sits outside a defensible 3-20x band, so the exit multiple is capped at 20.0x. A multiple that far out usually means EBITDA is the wrong denominator for this business.
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 | FY33 | FY34 | FY35 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD 4.2bn | USD 4.4bn | USD 4.6bn | USD 4.8bn | USD 5.0bn | USD 5.2bn | USD 5.4bn | USD 5.5bn | USD 5.7bn | USD 5.8bn | +3.6% |
| EBIT | USD 1.2bn | USD 1.3bn | USD 1.3bn | USD 1.4bn | USD 1.4bn | USD 1.5bn | USD 1.5bn | USD 1.6bn | USD 1.6bn | USD 1.7bn | +3.6% |
| NOPAT | USD 994.1m | USD 1.0bn | USD 1.1bn | USD 1.1bn | USD 1.2bn | USD 1.2bn | USD 1.3bn | USD 1.3bn | USD 1.3bn | USD 1.4bn | +3.6% |
| Add depreciation & amortisation | USD 131.3m | USD 137.5m | USD 143.6m | USD 149.6m | USD 155.5m | USD 161.1m | USD 166.5m | USD 171.6m | USD 176.4m | USD 180.8m | +3.6% |
| Less capital expenditure | USD -118.9m | USD -123.7m | USD -128.3m | USD -132.7m | USD -136.9m | USD -140.9m | USD -144.6m | USD -147.9m | USD -150.9m | USD -153.6m | +2.9% |
| Capex, % of revenue | 2.8% | 2.8% | 2.8% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% | 2.6% | 2.6% | - |
| Less increase in working capital | USD -47.5m | USD -44.7m | USD -44.1m | USD -43.2m | USD -41.9m | USD -40.5m | USD -38.7m | USD -36.6m | USD -34.3m | USD -31.7m | -4.4% |
| Free cashflow to firm | USD 959.0m | USD 1.0bn | USD 1.1bn | USD 1.1bn | USD 1.2bn | USD 1.2bn | USD 1.2bn | USD 1.3bn | USD 1.3bn | USD 1.4bn | +4.0% |
| Discount factor | 0.9565 | 0.8752 | 0.8008 | 0.7327 | 0.6704 | 0.6134 | 0.5613 | 0.5135 | 0.4699 | 0.4299 | - |
| Present value | USD 917.3m | USD 884.2m | USD 848.0m | USD 811.1m | USD 773.7m | USD 736.0m | USD 698.3m | USD 660.7m | USD 623.4m | USD 586.6m | - |
| Present Value Of The Forecast | USD 7.5bn | ||||||||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.89% | US 10-year Treasury (^TNX), 2026-11-02 |
| Equity risk premium | 4.23% | Damodaran, January 2026 |
| Beta | 1.115 | Reported 1.171, pulled toward 1.0 (Blume) |
| Cost of equity | 9.61% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.29% | Risk-free + 40bp, the spread for a AAA rating at 16.3x interest cover. Book interest / average debt was lower, at 3.3%. |
| Market capitalisation | USD 33.6bn | 94.0% of capital |
| Total debt | USD 2.2bn | 6.0% of capital, book value as a proxy |
| Tax rate | 17.8% | Effective, capped at statutory |
| WACC | 9.29% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
54% of EV
- Forecast FCFF, final year
- USD 1.4bn
- Capex at depreciation, working capital in reinvestment
- USD 1.5bn
- Less reinvestment at g/ROIC (5.5% of NOPAT)
- USD -79.7m
- Capitalised
- USD 1.4bn
- ROIC (reported)
- 45.7%
- Terminal value, undiscounted
- USD 20.8bn
- Terminal value, discounted
- USD 8.9bn
- Enterprise value
- USD 16.5bn
- Less net debt
- USD 2.1bn
- Equity value
- USD 14.4bn
Exit at 20.0x EBITDA
68% of EV
- Terminal value, undiscounted
- USD 36.9bn
- Terminal value, discounted
- USD 15.9bn
- Enterprise value
- USD 23.4bn
- Less net debt
- USD 2.1bn
- Equity value
- USD 21.3bn
Spread between methods: 39%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 7.29% | 913.10 | 964.39 | 1026.75 | 1104.07 | 1202.26 |
| 8.29% | 761.72 | 794.29 | 832.77 | 878.85 | 934.90 |
| 9.29% | 649.46 | 671.04 | 696.04 | 725.27 | 759.83 |
| 10.29% | 562.95 | 577.69 | 594.52 | 613.87 | 636.29 |
| 11.29% | 494.29 | 504.56 | 516.18 | 529.37 | 544.44 |
Outlined: this model. Green text: above today's price of 1678.19. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Actual | Model | Implied | Gap |
|---|---|---|---|---|
| Revenue growth, a year | 0.9% | 3.8% | 14.1% | |
| EBIT margin | 29.1% | 28.5% | 65.0% | |
| Discount rate | - | 9.3% | 5.5% |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.